Skip to main navigation Skip to search Skip to main content

Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes

  • Laurent Schmied*
  • , Patricia A. Olofsen
  • , Pontus Lundberg
  • , Alexandar Tzankov
  • , Martina Kleber
  • , Jörg Halter
  • , Mario Uhr
  • , Peter J.M. Valk
  • , Ivo P. Touw
  • , Jakob Passweg
  • , Beatrice Drexler*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Acquired aplastic anemia and severe congenital neutropenia (SCN) are bone marrow (BM) failure syndromes of different origin, however, they share a common risk for secondary leukemic transformation. Here, we present a patient with severe aplastic anemia (SAA) evolving to secondary chronic neutrophilic leukemia (CNL; SAA-CNL). We show that SAA-CNL shares multiple somatic driver mutations in CSF3R, RUNX1, and EZH2/SUZ12 with cases of SCN that transformed to myelodysplastic syndrome or acute myeloid leukemia (AML). This molecular connection between SAA-CNL and SCN progressing to AML (SCN-AML) prompted us to perform a comparative transcriptome analysis on nonleukemic CD34high hematopoietic stem and progenitor cells, which showed transcriptional profiles that resemble indicative of interferon-driven proinflammatory responses. These findings provide further insights in the mechanisms underlying leukemic transformation in BM failure syndromes.

Original languageEnglish
Pages (from-to)5540-5546
Number of pages7
JournalBlood Advances
Volume4
Issue number21
DOIs
Publication statusPublished - 10 Nov 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes'. Together they form a unique fingerprint.

Cite this